Plain language summary of Trifluridine/Tipiracil and Bevacizumab for refractory metastatic colorectal cancer: The SUNLIGHT Study
This Plain Language Summary of publication article (PLSP) from Future Oncology describes the phase 3 SUNLIGHT trial, which tested the combination of orally administered trifluridine/tipiracil and intravenously administered bevacizumab in patients with metastatic colorectal cancer (mCRC) that did not respond to previous treatments. The study aimed to compare the survival and effectiveness of this combination in slowing cancer progression.
Visit the site using this link to read the article.
This PLSP is based on an article called ‘Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer’ and was published in The New England Journal of Medicine.
Visit The New England Journal of Medicine using the link to read the original article.